2024 Year in Review
Read the UC Davis School of Medicine 2024 Year in Review.
School of Medicine
Two decades of advancing health and mental health equity
Transformative research, training and community engagement expand access to care and improve health outcomes
Top Stories
-
MIND InstituteAPRIL 02, 2026Regulatory T cells altered in children with autism
Two new studies from the UC Davis MIND Institute highlight the possible role of immunosuppressive cells on neuroinflammation and behavior in autistic children.
Read More -
Neurological HealthAPRIL 01, 2026NIH awards $15.8 million to UC Davis Health for major Hispanic-Latino brain health study
The NIH has awarded neurologist and dementia expert Charles DeCarli a $15.85 million grant to support one of the nation’s most extensive studies on brain aging in Hispanic-Latino communities.
Read More -
School of MedicineMARCH 31, 2026School of Medicine students spotlight global health inequities affecting displaced communities
UC Davis Health hosted a conference spotlighting major health gaps facing displaced communities worldwide and strategies to address them.
Read More -
School of MedicineMARCH 26, 2026Two researchers elected as AAAS Fellows for shaping science of neurological conditions
Two UC Davis School of Medicine faculty members have joined a century-long legacy of distinguished UC Davis AAAS fellows.
Read More -
MIND InstituteMARCH 25, 2026New MIND Institute pathway connects HBCU students with research careers
The UC Davis MIND Institute is offering a summer research pathway program for students from Xavier University of Louisiana, a historically Black university.
Read More -
School of MedicineMARCH 20, 2026
Match Day reveals life-changing news for 121 UC Davis medical students
Cheers, tears and relief mark Match Day as 121 students discover where they will train and take the next step toward becoming physicians.
Read More -
School of MedicineMARCH 19, 2026How an imbalanced gut microbiome worsens chronic kidney disease
Researchers have identified how chronic kidney disease turbocharges E. coli toxin production, worsening the disease. An investigational drug might break the destructive feedback loop.
Read More
Publications
UC Davis Health Magazine
Read the latest issue of UC Davis Health, a publication of the UC Davis School of Medicine.
Strategic Plan
See the Strategic Plan for the UC Davis School of Medicine.
